ey0015.4-2 | Important for clinical practice | ESPEYB15
W Bonfig , A Lindberg , M Carlsson , W Cutfield , D Dunger , C Camacho-Hübner , RW Holl
ey0015.8-7 | Important for Clinical Practice | ESPEYB15
D El-Maouche , CJ Hargreaves , N Sinaii , A Mallappa , P Veeraraghavan , DP Merke
ey0015.8-17 | New Paradigms | ESPEYB15
LR Strachan , TJ Stevenson , B Freshner , MD Keefe , D Miranda Bowles , JL Bonkowsky
ey0015.9-7 | Growth, growth hormone and puberty in chronic diseases: novel insights from clinical practice | ESPEYB15
H David , C Aupiais , B Louveau , P Quartier , E Jacqz-Aigrain , JC Carel , D Simon
ey0015.10-18 | Psychology and quality of life | ESPEYB15
D Dybdal , JS Tolstrup , SM Sildorf , KA Boisen , J Svensson , AM Skovgaard , GK Teilmann
ey0015.13-10 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
R Atun , JI Davies , EAM Gale , T Barnighausen , D Beran , AP Kengne
ey0015.13-18 | Advances in the Diagnosis and Management of Congenital Hypothyroidism | ESPEYB15
L Mehran , D Khalili , S Yarahmadi , A Amouzegar , M Mojarrad , N Ajang , F Azizi
ey0015.14-12 | The ‘nocebo’ effect: psychogenic but truly harmful | ESPEYB15
A Gupta , D Thompson , A Whitehouse , T Collier , B Dahlof , N Poulter , R Collins , P Sever , Investigators ASCOT
ey0020.3-2 | Novel Treatments for Rare Skeletal Disorders | ESPEYB20
VM Breinholt , PH Mygind , ED Christoffersen , Y Zhang , S Ota , R Will Charlton , D Viuff
ey0020.5-6 | Clinical Guidance and Studies | ESPEYB20
AB Hansen , CH Renault , D Wojdemann , P Gideon , A Juul , RB Jensen